Correlation Between Taxus Cardium and Replimune
Can any of the company-specific risk be diversified away by investing in both Taxus Cardium and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taxus Cardium and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taxus Cardium Pharmaceuticals and Replimune Group, you can compare the effects of market volatilities on Taxus Cardium and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taxus Cardium with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taxus Cardium and Replimune.
Diversification Opportunities for Taxus Cardium and Replimune
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Taxus and Replimune is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Taxus Cardium Pharmaceuticals and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Taxus Cardium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taxus Cardium Pharmaceuticals are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Taxus Cardium i.e., Taxus Cardium and Replimune go up and down completely randomly.
Pair Corralation between Taxus Cardium and Replimune
If you would invest 1,256 in Replimune Group on November 2, 2024 and sell it today you would earn a total of 106.00 from holding Replimune Group or generate 8.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 5.26% |
Values | Daily Returns |
Taxus Cardium Pharmaceuticals vs. Replimune Group
Performance |
Timeline |
Taxus Cardium Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Replimune Group |
Taxus Cardium and Replimune Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Taxus Cardium and Replimune
The main advantage of trading using opposite Taxus Cardium and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taxus Cardium position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.Taxus Cardium vs. Revolution Medicines | Taxus Cardium vs. Blueprint Medicines Corp | Taxus Cardium vs. Sana Biotechnology | Taxus Cardium vs. Kymera Therapeutics |
Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |